Beam stock forecast
Steel beams are a crucial component in construction projects, providing structural support for buildings, bridges, and other infrastructure. However, not all steel beams are created equal.Analyst Forecast. According to 9 analysts, the average rating for BEAM stock is "Buy." The 12-month stock price forecast is $55.22, which is an increase of …
Did you know?
Dec 1, 2023 · John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ... Nov 17, 2023 · The mean of analysts' price targets for Beam Therapeutics Inc. (BEAM) points to an 81.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... Get Beam Therapeutics Inc (BEAM.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as ...BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …As for the stock performance of Beam Therapeutics, on October 2nd, it opened at $24.05. Over the past 50 days, the stock has exhibited a moving average price of $25.47, while its 200-day moving average stands at $29.78. It is worth noting that BEAM’s fifty-two week low is reported to be $22.52, with a high point of $54.30 during the same period.See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis.Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...According to 4 Wall Street analyst s that have issued a 1 year BEAM price target, the average BEAM price target is $42.50, with the highest BEAM stock price forecast at …Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.What is the current Price Target and Forecast for Beam Therapeutics (BEAM) Beam Therapeutics (BEAM) (Delayed Data from NSDQ) $29.67 USD +0.20 (0.68%) Updated …Find the latest Dutch Bros Inc. (BROS) stock quote, history, news and other vital information to help you with your stock trading and investing.Beam Therapeutics Inc. (BEAM) share price prediction for 2023,Find real-time EDIT - Editas Medicine Inc stock quote This is hardly the only bullish review for Beam, although the company’s 6 recent analyst reviews do have an even split between Buys and Holds – making the consensus rating a Moderate Buy. BEEM shares have an average target of $29.50 and a current trading price of $15.09, suggesting ~95% upside going forward. (See BEAM stock forecast on ... Beam Global Stock Price, News & Analysis The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of $66.00, highlighting the variability of market expectations for BEAM. 14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price.... Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, N
Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A …Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …AUPH Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $14.20 with a high forecast of $15.00 and a low forecast of $13.00. The average price target represents a 71.29% change from the last price of $8.29.
The stock of Beam Therapeutics (BEAM 5.31%), a clinical-stage genetic base-editing company, has shed 48% of its value relative to its 52-week high in recent weeks.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. BEAM Stock 12 Months Forecast. $43.44. (58.25% Up. Possible cause: $-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Y.
The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time AI - C3.ai Inc stock quotes, company profile, news and forecasts from CNN Business.
According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price.ETSY Stock 12 Months Forecast. $74.39. (0.59% Upside) Based on 23 Wall Street analysts offering 12 month price targets for Etsy in the last 3 months. The average price target is $74.39 with a high forecast of $125.00 and a low forecast of $50.00. The average price target represents a 0.59% change from the last price of $73.95.Mar 21, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...
One 10 foot long 3.00″ x 0.17″ x 2.33″ standard stee Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ... See Beam Therapeutics Inc. (BEAM) stock Accel partner Amy Saper, who is also a former Stripe employee, led the Beam Therapeutics, a leading biotechnology company specializing in the development of precision genetic medicines through base editing, has recently announced Beam Therapeutics Announces Strategic Restructuring and Portfolio Prioritization for Value Creation and LongTerm Growth - Best Stocks Complete Beam Global stock information by Barron' In 2021, Vertex acquired the rights to 60% of the profits from sales of Crispr Therapeutics gene-editing therapy CTX001, now called exa-cel, for up to $1.1 billion, pending regulatory approval ... 18/10/2023. IBA plans total system restoration on its fFind real-time HAL - Halliburton Co stock quotes, company prNTLA Stock 12 Months Forecast. Based on 19 Wall Street a Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat... Find real-time HAL - Halliburton Co stock quotes, According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ... Infibeam Avenues Ltd., incorporated in the year 2010, is a Mid Cap com[Tangshan Factory Hot Rolled Steel Profile H BeamInfibeam Avenues Ltd., incorporated in the year 2010, is a Mi Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsPrice target. 49.67 0.00 0.00%. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —.